However, Sharma et al., have demonstrated that in OSCC cells resistance to cisplatin does not depend on SOX2 levels or its tumor-initiation capacity, suggesting the involvement of another stem cell factor promoting the proliferation and growth of tumor cells [43]. This evidence concerns the gene SOX2 and neoplasm.